ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

Empower your portfolio: Real-time discussions and actionable trading ideas.

Key stats and details

Current Price
-
Bid
-
Ask
-
Volume
-
0.00 Day's Range 0.00
0.00 52 Week Range 0.00
Previous Close
-
Open
-
Last Trade
Last Trade Time
-
Average Volume (3m)
-
Financial Volume
-
VWAP
-

GILD Latest News

Gilead Stops Development of Lung Drug Cicletanine After Missing Study Goal

By Peter Loftus Gilead Sciences Inc. (GILD) has discontinued development of a treatment for a rare lung disease after it failed to meet its efficacy goal in a clinical trial. The drug...

Seven Summits Research Releases Comments on Microsoft, Amazon.com, Celgene, Starwood Hotels and Gilead Sciences

CHICAGO, Oct. 19 /PRNewswire/ -- Seven Summits Strategic Investments releases its Stocks To Watch Guide. The Seven Summits Strategic Investments Stocks To Watch Guide (go to:...

US EQUITIES WEEK AHEAD: More 3Q Results; Windows 7 Launches

Boeing Co. (BA), DuPont Co. (DD), Pfizer Inc. (PFE) and Microsoft Corp. (MSFT) are among the major companies posting quarterly results next week. Meanwhile, economic reports are expected to show...

Critical Alerts for US Steel, Gilead, Dow Chemical, Banco Bradesco, and Marvel Entertainment Released by Seven Summits Research

CHICAGO, Oct. 5 /PRNewswire/ -- Seven Summits Research issues PriceWatch Alerts for X, GILD, DOW, BBD, and MVL. Seven Summits Strategic Investments' PriceWatch Alerts are available at...

Gilead: US Requests Documents About Angina Drug

By Carla Mozee Biotech firm Gilead Sciences Inc. (GILD) said Friday that it has received a subpoena from the U.S. Department of Health and Human Services requesting documents about the...

MARKET SNAPSHOT: As Earnings Doubts Fade, Stocks Set Sights On GDP

By Nick Godt With any concerns about the second-quarter earnings season mostly behind, the market will now key on more signs of "green shoots" in big economic reports, starting with the...

UPDATE: Gilead Sciences 2Q Profit Up 31% On HIV Drug Sales

Gilead Sciences Inc.'s (GILD) second-quarter profit climbed 31% on strong sales of its core HIV treatment franchise, but its disappointing revenue outlook sent shares lower. The Foster City...

Gilead Projects 2009 Net Product Revenue $6.1 Billion-$6.2 Billion

Gilead Sciences Inc. (GILD) raised its projection for 2009 net product revenue to $6.1 billion to $6.2 billion in its first update since April's $1.4 billion acquisition of CV Therapeutics. The...

Gilead Sciences 2Q Profit Up 31% On Higher HIV Product Sales

Gilead Sciences Inc.'s (GILD) second-quarter profit climbed 31% as the biopharmaceutical company reported higher sales from its HIV products and added revenue from its acquisition of heart-drug...

Gilead Sciences Files Patent Infringements Suit Against Teva

Gilead Sciences Inc. (GILD) said on Thursday it filed a lawsuit against Israeli-based Teva Pharmaceutical Industries Inc. (TEVA) and its U.S. subsidiary for infringement of two patents tied to two...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10000000DE
40000000DE
120000000DE
260000000DE
520000000DE
1560000000DE
2600000000DE

GILD - Frequently Asked Questions (FAQ)

What is the current Gilead Sciences share price?
The current share price of Gilead Sciences is 0.00 €
What is the 1 year trading range for Gilead Sciences share price?
Gilead Sciences has traded in the range of 0.00 € to 0.00 € during the past year

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
WS3D25Solid World Group spa
0.2486 €
(38.11%)
61.48k
WNUS26Nusco Spa
0.1344 €
(29.73%)
9k
WERFOLaboratorio Farmaceutico Erfo SPA
0.0499 €
(20.53%)
1,000
WRKT25Roket Sharing Company Spa
0.003 €
(20.00%)
91.88k
S3DSolid World Group spa
2.41 €
(18.72%)
91.58k
WAMB26Ambromobiliare SpA
0.064 €
(-28.89%)
10k
1NKLANikola Corp
1.4642 €
(-11.26%)
32.07k
UBAUbaldi Costruzioni SPA
3.9995 €
(-10.32%)
11.2k
ELBEdgelab
6.70 €
(-9.46%)
14k
EVAAskoll Eva SPA
0.1455 €
(-8.49%)
150k
TITTelecom Italia SpA
0.2546 €
(4.34%)
190.72M
ISPIntesa Sanpaolo Spa
3.92 €
(-0.24%)
37.03M
TITRTelecom Italia
0.30 €
(3.95%)
24.37M
SPMSaipem Spa
2.71 €
(-1.38%)
19.96M
BPEBper Banca SPA
6.082 €
(1.23%)
10.41M

Discussion

View Full Feed
treasurevalley treasurevalley 4 minutes ago
Oh my poor Dragon even your alter ego can't stand your daily childish rants and seems to have gone missing. The Doc says he will see you for free, but you have to pay for the creams. Hiding you say I hope you buried havnagoatin under that bridge with your other I-HUB names. We bought more DPLS sorry
DPLS
Donotunderstand Donotunderstand 4 minutes ago
DEC 12

scam post
NKLA
Chiron Chiron 4 minutes ago
This should be at .002 - .003, You all need to post it everywhere. 
ASII
DiscoverGold DiscoverGold 4 minutes ago
$SPX 2-year ROC > 45%. Historical stats negative, but skewed pre. and post 1996
By: Nautilus Research | January 6, 2025

• $spx #equities SPX 2-year ROC > 45%. Historical stats negative, but skewed pre. and post 1996.

pbs.twimg.com/media/GgnKbZtWUAAYcvU?for
SPX
955 955 5 minutes ago
Trump certification yesterday is HUGE news for F&F. Civil War averted. SP headed back to $5 and beyond.
splintered sunlight splintered sunlight 5 minutes ago
Yes

Happy I stayed long this one.....
KRTL
crowin crowin 5 minutes ago
Because this is the stinky stock world and these SCAMS are fun to expose.

Slap the ask and just flip and be Happy.

Again make a buck and don't get GREEDY and stuck................
RDAR
Chiron Chiron 5 minutes ago
Great news out today BB, bring in the masses
ASII
SkeBallLarry SkeBallLarry 5 minutes ago
" Mr. Trump to speak *Live* on Real American Voice " ...
Donotunderstand Donotunderstand 5 minutes ago
should we trust it ?

yes

and give them credit
FNMA
Invest-in-America Invest-in-America 6 minutes ago
XTIA: Could we please have a spectacular " VERTICAL-TAKEOFF-&-LANDING " routine today --- PRICE wise that is, which ends up on Planet JUPITER , maybe??? (No puns intended.)
XTIA
max mastiff max mastiff 6 minutes ago
Let’s go 🍺🍺🇺🇸🇺🇸🦍🦍
XTIA
TommyJ7651 TommyJ7651 6 minutes ago
I'm confident they will get it done when the time is right. In all likelyhood It would already have been done but like Dan said in the interview the market has been horrible. I don't want to do a deal at 12 cents a share and neither do Keith. We are going to have to wait for the market to turn aroun
FFMGF
PEACHMAN PEACHMAN 6 minutes ago
Thanks for inviting me to review MGON I like what I see and have the patience to buy and hold longer term
MGON
Ricco79 Ricco79 6 minutes ago
Bill Ackman is good friends with DJT and Elon Musk. Why should Ackman be satisfied with $5 or why should Elon and DJT not give him more.
Think easy!
DJT
Hi_Lo Hi_Lo 6 minutes ago
From CSE which, as opposed to you, is the authority concerning the matter:

https://webfiles.thecse.com/resource/Policy_5_-_Timely_Disclosure_Trading_halts_and_Posting.pdf?pk19wglTGczzzFNIci3V8AB1e_GDbe_G

The onus is the Listed Issuer to ensure appropriate dissemination
TWOH
AMB67 AMB67 6 minutes ago
Vivos' share price should be at least $5 now and at least $60 after IDE approval.

Back in 2018, Sirtex was bought out by an overseas consortium at $25.10 per share. Sirtex ONLY treated ONE indication--liver cancer. RadioGel can treat OVER 18 indications.

It is constant
RDGL
georgie18 georgie18 6 minutes ago
Thanks Pink...🥳
SkeBallLarry SkeBallLarry 6 minutes ago
" Mr. Trump to speak *Live* on Real American Voice " ...
Donotunderstand Donotunderstand 7 minutes ago
sounds very good
thanks

the JPS are not a holding for WORST CASE

if JPS were that certain to hit say PAR=25 - they would be trading 20+ right now - today

the PPS for the JPS suggests there is still more risk than you note

but again
FNMA
DavidLeeRoth DavidLeeRoth 7 minutes ago
That alone puts ASII on track for 51 million in revenue😎 That’s not including what else is coming! ASII WINNING💰
ASII
DiscoverGold DiscoverGold 7 minutes ago
Technical Overbought/Sold Composite
By: Isabelnet | January 7, 2025

• S&P 500

With a reading of 64.39, the US stock market is no more overbought, suggesting a potential shift in investor sentiment and a possible opportunity for market participants to reasses
eagpup eagpup 7 minutes ago
Have they been able to pass the certification or do they need help?
XERI
quester614 quester614 7 minutes ago
OMG so now after years of hearing of Retacell and Nexboard we get Nano technology. LOLOLOLOL This is the new marketing campaign. Announce another change in development.
I guess getting the NFPA 286 test done with the unknown experienced chemist to a whole new developing technology that is th
XERI

Your Recent History

Delayed Upgrade Clock